Back to Journals » Drug Design, Development and Therapy » Volume 12 » CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Please verify you are not a robot.
Back to Journals » Drug Design, Development and Therapy » Volume 12 » CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Please verify you are not a robot.